Q2 results approved and related party policy revised
RPGLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 14.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved unaudited results for September 30, 2026 and revised its related party policy. Consolidated Q2 revenue rose 16% to Rs 211.64 crore, while net profit fell 23% to Rs 28.22 crore; the prior-year quarter included a Rs 11.22 crore exceptional fire-related gain. H1 revenue was Rs 407.33 crore and net profit Rs 58.79 crore. The auditor reported no material misstatement.
Revenue growth is positive, but lower profit may weigh on sentiment. The policy revision adds governance focus; acquisitions limit direct comparisons.